2nd Quarter - Report

COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

Firm
Client
Income
$220,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Biopharmaceutical innovation and intellectual property policy issues; Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); induced infringement.

LobbyistCovered position, as disclosed
KRISTA CARVER —
NATALIE DERZKO —
ANDREW DAVID LAZEROW —
JENNIFER L PLITSCH —
MICHAEL STERN —

Bills named: S. 1096 (119th)

Health Issues HCR

Proposed amendments to the Inflation Reduction Act (P.L. 117-169); Biosimilars Access and Affordability Act (S. 5459); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); EPIC Act of 2025 (S. 832); H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Increasing Transparency in Generic Drug Applications Act (S.1302); Stop STALLING Act (S. 1095); S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes; Interagency Patent Coordination and Improvement Act of 2025 (S. 1097); approval pathways; Expedited Access to Biosimilars Act (S. 1414); Biosimilar Red Tape Elimination Act (S. 1954); USFDA-PTO collaboration; FDA reductions in force and FDA reforms; drug supply chain; right to try; ORPHAN Cures Act (H.R. 946); H.R.1 - One Big Beautiful Bill Act; priority review vouchers; Family Vaccine Protection Act (H.R. 3701).

LobbyistCovered position, as disclosed
KRISTA CARVER —
NATALIE DERZKO —
RICHARD F KINGHAM —
ANDREW DAVID LAZEROW —
JENNIFER L PLITSCH —
MICHAEL STERN —

Contacted: SENATE

Bills named: S. 1302 (119th), S. 5459 (119th), H.R. 3701 (119th), S. 1096 (119th), S. 832 (119th), S. 1095 (119th), S. 1097 (119th), H.R. 1492 (119th), S. 1414 (119th), S. 1954 (119th), H.R. 946 (119th), S. 1040 (119th), H.R. 1 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.